Whitney & Co’s Lisata Therapeutics LSTA Stock Holding History

Whitney & Co’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	–	–	296
2018 Q3	$0	Hold	1	–	–	﹤0.01%	546
2018 Q2	$0	Hold	1	–	–	﹤0.01%	334
2018 Q1	$0	Buy	+1	New	+$69	﹤0.01%	309

Other funds holding LSTA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

TFO

Tarbox Family Office Newport Beach, California $616M AUM 18.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Whitney & Co's LSTA Position: Q4 2018 in Review

Whitney & Co sold out of Lisata Therapeutics (LSTA) in Q4 2018, closing a stake of 1 share.

Whitney & Co first reported a position in LSTA in Q1 2018 and held it in 3 quarters. The position peaked at $0 in Q3 2018. 27 funds tracked by Wall St. Rank hold LSTA as of Q4 2018.

Whitney & Co reported no remaining Lisata Therapeutics position as of Q4 2018 after selling out during the quarter.
Whitney & Co sold 1 Lisata Therapeutics share in Q4 2018.
Whitney & Co first reported a position in Lisata Therapeutics in Q1 2018 and held it in 3 quarters.
Whitney & Co's Lisata Therapeutics position peaked at $0 in Q3 2018.
27 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2018.

Based on Whitney & Co's 13F filing for Q4 2018, filed 7 Feb 2019.